SCHEMBL13630652

SCHEMBL13630652

CC(C)Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.65
PTGS2 P35354 5/20 0.65
KDM4E B2RXH2 4/20 0.65
CYP1A1 P04798 4/20 0.65
CYP1B1 Q16678 4/20 0.65
LMNA P02545 3/20 0.65
ALOX12 P18054 1/20 0.65
TTR P02766 4/20 0.59
MEN1 O00255 3/20 0.59
MAPT P10636 3/20 0.59
KMT2A Q03164 3/20 0.59
ALOX5 P09917 3/20 0.59
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CA3 P07451 2/20 0.59
CA4 P22748 2/20 0.59
CA6 P23280 2/20 0.59
CA5A P35218 2/20 0.59
CA7 P43166 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20024678 0.86 ALDH1A3 (0.68) PTGS2KDM4ECYP1A1CYP1B1LMNA
SCHEMBL13630653 0.86 PTGS2 (0.67) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL20929819 0.83 PTGS1 (0.57) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL2470272 0.81 APP (0.57) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL9605425 0.81 PTGS1 (0.59) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL27224304 0.80 PTGS2 (0.54) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL392666 0.80 CYP1A1 (0.72) PTGS1PTGS2KDM4ECYP1A1CYP1B1
SCHEMBL392667 0.80 CYP1A1 (0.72) PTGS1PTGS2KDM4ECYP1A1CYP1B1
Resveratrol 4'-Methyl Ether SCHEMBL4732963 0.79 PTGS2 (1.00) PTGS1PTGS2KDM4ECYP1A1CYP1B1
Resveratrol 4'-Methyl Ether SCHEMBL563262 0.79 PTGS2 (1.00) PTGS1PTGS2KDM4ECYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013037985-A1 PHARMACEUTICAL COMBINATIONS INCLUDING ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS GENMEDICA THERAPUTICS SL (ES) 2013-03-21 WO disclosed
WO-2009138437-A1 SALICYLATE CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS GENMEDICA THERAPEUTICS SL (ES) 2009-11-19 WO disclosed